Discovering new drugs to fight TB

August 30, 2011, Victoria University

(Medical Xpress) -- Research at Victoria University is targeting new drugs to fight drug-resistant and other forms of tuberculosis (TB).

In June this year the first case of extensively-drug resistant TB in New Zealand was reported. The strain of Mycobacterium isolated is the most drug-resistant strain recorded to date in Australasia.

Although TB has slipped under the radar in New Zealand, around 300 new cases are diagnosed here every year. Around the world there are a massive 9.4 million new cases annually and 1.7 million people die from the disease. TB takes about the same number of lives as /—and more than malaria.

Ronan O’Toole, a senior lecturer in the School of Biological Sciences, leads a team of Victoria researchers looking for innovative new compounds to help eliminate Mycobacterium tuberculosis.

He says current clinical TB drugs have been around for more than 30 years and resistance has become a major problem.

"People with TB have to take antibiotics for six months, and that’s the short course. Some patients may not stick with the treatment to the end, and when drugs are not used appropriately, you can eventually get resistance."

In 2009, there were a quarter of a million new cases of people with multi-drug resistant tuberculosis.

Dr O’Toole recently spent time studying multi- and extensively-drug of M. tuberculosis in level 3 containment facilities at the Centre for TB Research at John Hopkins University in Baltimore.

"One of them was resistant to 10 of the available tuberculosis drugs. This leaves few drugs to treat such strains with."

With funding from the Health Research Council of New Zealand and the Wellington Medical Research Foundation, Dr O’Toole has been investigating techniques to speed up screening for to fight TB.

He and his students have developed novel procedures for identifying compounds that inhibit M. tuberculosis. These are then applied to libraries of synthetic compounds, and natural products isolated from and marine organisms, to highlight promising treatments.

"Our techniques allow us to screen thousands of compounds much faster to see where possible new treatments might come from."

Using targeted screening protocols, they can also pre-select for compounds which have a new mode of action against the cell of M. tuberculosis.

One strand of the work has seen the researchers testing native plants to see if they can help in the fight against TB. Dr O’Toole’s group has prepared extracts from a variety of New Zealand plants and found that a number of them inhibited the growth of M. tuberculosis.

The most promising extract came from the inner bark of the Pukatea tree (Laurelia novae-zelandiae). This is of interest, says Dr O’Toole, as Pukatea bark extract was reportedly used by Maori as a traditional treatment for tuberculosis ulcers. The findings indicate the potential that native plants and other organisms may have as sources of tuberculosis drugs.

In a joint project with the TB research group at the Malaghan Institute, the researchers are also trying to find out more about latent forms of the bacteria.

Dr O’Toole says the World Health Organisation has estimated that up to one-third of the world’s population carries M. tuberculosis in its latent form.

"People with latent TB are not infectious and most will not develop the symptoms of active TB but the WHO estimate highlights the extent of the reservoir that exists for the bacterium."

One goal of the project is to find out what signals drive the bacteria to enter and exit latency. A second objective is to find compounds that will kill the M. cells that are present in latent TB cases.

"Currently, we have few drugs that are effective against latent TB," says Dr O’Toole.

Despite the size of the problem, Irish-born Dr O’Toole is optimistic about the future.

"With continued investment in discovering and developing new treatments, I am confident it is a disease we will get on top of in my lifetime."

Related Stories

Recommended for you

Don't hold your nose and close your mouth when you sneeze, doctors warn

January 15, 2018
Pinching your nose while clamping your mouth shut to contain a forceful sneeze isn't a good idea, warn doctors in the journal BMJ Case Reports.

Surfers three times more likely to have antibiotic-resistant bacteria in guts

January 14, 2018
Regular surfers and bodyboarders are three times more likely to have antibiotic resistant E. coli in their guts than non-surfers, new research has revealed.

New antifungal provides hope in fight against superbugs

January 12, 2018
Microscopic yeast have been wreaking havoc in hospitals around the world—creeping into catheters, ventilator tubes, and IV lines—and causing deadly invasive infection. One culprit species, Candida auris, is resistant ...

Dengue takes low and slow approach to replication

January 11, 2018
A new study reveals how dengue virus manages to reproduce itself in an infected person without triggering the body's normal defenses. Duke researchers report that dengue pulls off this hoax by co-opting a specialized structure ...

Different strains of same bacteria trigger widely varying immune responses

January 11, 2018
Genetic differences between different strains of the same pathogenic bacterial species appear to result in widely varying immune system responses, according to new research published in PLOS Pathogens.

Human protein may aid neuron invasion by virus that causes hand, foot, and mouth disease

January 11, 2018
A human protein known as prohibitin may play a significant role in infection of the nervous system by EV71, one of several viruses that can cause hand, foot, and mouth disease. Issac Too of the National University of Singapore ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.